Clinical Trials Logo

Depressive Disorder clinical trials

View clinical trials related to Depressive Disorder.

Filter by:

NCT ID: NCT02830399 Completed - Clinical trials for Major Depressive Disorder

Clinical Trial on Efficacy of rTMS to Improve ECT in Treatment-Resistant Depression

STIMAGNECT
Start date: July 15, 2016
Phase: N/A
Study type: Interventional

It's a prospective, multicentric, randomized, controlled study concerning 56 patients with treatment-resistant depression (TRD). The main objective of this study was to evaluate the efficacy of priming repeated Transcranial Magnetic Stimulation (rTMS) sessions before Electroconvulsive therapy (ECT) for treatment of TRD patients. The primary outcome will be the depressive symptoms intensity measured with the Hamilton Rating Scale For Depression (HAMD-21 items) after 5 ECT. The secondary outcome is to evaluate the safety and most particularly the cognitive effects of this association.

NCT ID: NCT02829671 Completed - Clinical trials for Major Depressive Disorders

Loneliness and Occurrence of Suicide Attempts and Suicidal Ideas

SOLSTIS
Start date: October 11, 2016
Phase: N/A
Study type: Interventional

Suicide is a major health problem that causes annually a million death worldwide. Loneliness is known to be associated with suicidal ideation in minors and to be related with suicidal risk in elderly people. However little is known about this association in a middle-aged population. Loneliness is a modifiable factor with suitable psychotherapeutic measures, it is essential to improve the scientific and medical knowledge about the link between this feeling and suicide risk in a population of depressed patients in middle age. The main objective is the study of the relationship between loneliness and the occurrence of suicidal behavior (SB) in major depressed adult population over 12 months. The secondary objectives are: - Identification of risk factors (clinical, neuropsychological and biological) of the occurrence of SB within a clinical population and their interaction; - Identification of predictive factors (clinical, neuropsychological, biological) therapeutic response to antidepressant in the context of depression.

NCT ID: NCT02828072 Completed - Depression Clinical Trials

Sudarshan Kriya Yoga and Cardiac Autonomic Control in Patients With Anxiety-Depression Disorders

Start date: March 2011
Phase: N/A
Study type: Interventional

The effects of Sudarshan Kriya Yoga (SKY) on autonomic function in patients with anxiety-depression disorders is unknown. Thus, the authors will investigate cardiac autonomic control in a population of patients with anxiety-depression disorders which will undergo a specific SKY treatment.

NCT ID: NCT02823418 Completed - Clinical trials for Depression, Postpartum

Neuraxial Labor Analgesia and the Incidence of Postpartum Depression

Start date: August 1, 2014
Phase:
Study type: Observational [Patient Registry]

Postpartum depression (PPD) affects approximately 15% of women during the first year after giving birth, and is common across cultures. The etiology of postpartum depression is not totally clear. The severe pain experienced during childbirth was reported to be associated with the development of postpartum depression. The purpose of the present study is to evaluate whether use of neuraxial labor analgesia can reduce the incidence of postpartum depression.

NCT ID: NCT02822443 Completed - Anxiety Disorder Clinical Trials

Improve: Integrating Emotion Focused Components Into Psychological Therapy

Improve
Start date: April 2015
Phase: Phase 2
Study type: Interventional

The primary purpose of this study is to compare the efficacy of two treatment-as-usual (TAU) conditions: TAU with integration of emotion focused components (EFT) and TAU with focus on self-regulation (SR). Especially the long-term efficacy is evaluated with a focus on differential effects. Moreover, the mechanisms of change of both conditions are investigated.

NCT ID: NCT02818075 Completed - Clinical trials for Postpartum Depression

Mobile Phone Based Peer Support to Prevent Postpartum Depression Among Adolescent Mothers

Start date: April 2016
Phase: N/A
Study type: Interventional

This pilot study will evaluate the feasibility and acceptability of a mobile phone based peer support intervention among adolescent mothers. Half of the participants will receive usual care plus the peer support intervention and the other half of the participants will receive usual care only.

NCT ID: NCT02816138 Completed - Clinical trials for Major Depressive Disorder

Depressed Mood Improvement Through Nicotine Dosing (Depressed MIND Study)

Start date: October 2016
Phase: Phase 4
Study type: Interventional

Late-life depression is characterized by both affective (mood) symptoms and cognitive deficits. There is currently no intervention that may provide consistent benefits to both mood and cognitive performance. Agonist activity at the nicotinic acetylcholine receptors via transdermal nicotine patches may provide benefit to both mood and cognition, working through nicotine's effects on brain neural networks, specifically the cognitive control network and default mode network. In this initial pilot project, the investigators will test this hypotheses in 15 nonsmoking depressed elders with subjective cognitive impairment. Following baseline neuroimaging and cognitive testing, participants will receive 12 weeks of open-label transdermal nicotine. Afterwards, participants will repeat neuroimaging and cognitive assessments.

NCT ID: NCT02815813 Completed - Obesity Clinical Trials

Lifestyle Intervention for Young Adults With Serious Mental Illness

Start date: July 3, 2017
Phase: N/A
Study type: Interventional

This is a four year project evaluating the effectiveness of a group-based lifestyle intervention (PeerFIT) supported by mobile health (mHealth) technology and social media compared to Basic Education in fitness and nutrition supported by a wearable Activity Tracking device (BEAT) in achieving clinically significant improvements in weight loss and cardiorespiratory fitness in young adults with serious mental illness (SMI).

NCT ID: NCT02813174 Completed - Clinical trials for Postpartum Depression

Personality Style and Self Compassion in Postpartum Depression: An Online Prevention Study

Start date: June 2016
Phase: N/A
Study type: Interventional

The primary aim of this study is to assess the relationship between personality style, self-compassion and depression during pregnancy, to identify psychological risk factors, particularly personality styles, that may contribute to the onset of PPD. Additionally, the study will provide support for the effectiveness of Internet-based Compassionate-Mind Training (iCMT) as a prevention intervention for Postpartum Depression (PPD) for women in the 2nd and 3rd trimester of pregnancy. The study will also assess differences along personality predictors and depression severity as they relate to intervention outcomes (i.e. depression in postpartum and self-compassion) and engagement. The researchers hypothesize that women both at high and low risk for PPD will receive benefits from the intervention, however, those who endorse more maladaptive personality traits will likely engage and benefit less than those who do not endorse these traits.

NCT ID: NCT02811302 Completed - Clinical trials for Respiratory Depression

PRediction of Opioid-induced Respiratory Depression In Patients Monitored by capnoGraphY

PRODIGY
Start date: April 7, 2017
Phase: N/A
Study type: Interventional

PRODIGY is a prospective, multi-center, post-market, international cohort study. The primary objective of this study is to derive a score to identify subjects at risk to have respiratory depression (RD) episodes in patients undergoing opioid therapy in the hospital ward and monitored by capnography. The score will be derived by using subjects within the derivation cohort and internally validated using subjects within the validation cohort. The primary endpoint used to derive the score will be the occurrence of RD episodes derived by Capnostream 20p device memory data combined with clinical data and validated by an independent Clinical Endpoint Committee (CEC) during the study course.